NEWS & VIEWS

Global private equity and venture capital news and research

Private equity consortium increases offer for Biomet to $11.4bn

8 Jun 2007

The board of directors of Warsaw, Indiana-headquartered Biomet, a specialist in the orthopedic and musculoskeletal product industry, has unanimously recommended to shareholders an increased offer from a private equity consortium including The Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. and TPG to acquire Biomet for $46 per share in cash, or an equity value of $11.4bn.

The board of directors of Warsaw, Indiana-headquartered Biomet, a specialist in the orthopedic and musculoskeletal product industry, has unanimously recommended to shareholders an increased offer from a private equity consortium including The Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. and TPG to acquire Biomet for $46 per share in cash, or an equity value of $11.4bn.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016

log